Related Experiment Videos

Preventable medication-related events in hospitalised children in New Zealand

Desireé L Kunac1, David M Reith

  • 1School of Pharmacy, University of Otago, Dunedin, New Zealand. desiree.kunac@otago.ac.nz

Insights

Preventable medication errors are frequent in hospitalized children, with over half of harmful events being avoidable. Dosing errors and antibacterial use, especially intravenous, are key targets for prevention.

Area of Science:

  • Pediatric pharmacology
  • Patient safety
  • Healthcare quality improvement

Background:

  • Medication-related events (MREs) pose a significant risk to hospitalized children.
  • Identifying and preventing these events is crucial for improving pediatric patient safety.

Purpose of the Study:

  • To assess the incidence and characteristics of preventable MREs in pediatric inpatients.
  • To evaluate the effectiveness of different methods for detecting MREs.
  • To identify priority areas for preventing MREs in children.

Main Methods:

  • A 12-week prospective observational cohort study in a New Zealand pediatric ward.
  • Multifaceted approach to identify MREs, including chart review, voluntary reporting, parent interviews, and incident reporting.
  • Independent classification of MREs by three reviewers.

Main Results:

  • A high rate of preventable MREs was observed, with 92.2% of analyzed events being preventable.
  • Adverse Drug Events (ADEs) and potential ADEs were largely preventable (56.7% and 97.4%, respectively).
  • Improper dosing during prescribing and the use of antibacterial agents via intravenous administration were most frequently implicated in harmful events.

Conclusions:

  • Preventable MREs are common in pediatric inpatients, with significant potential for harm.
  • Chart review is more effective than voluntary or incident reporting for identifying MREs.
  • Targeting dosing errors and intravenous antibacterial use can significantly reduce preventable harm.
Abstract

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...